<DOC>
	<DOC>NCT00289159</DOC>
	<brief_summary>To determine wether multimodal MRI (conventinal T1 and T2 sequences, diffusion, magnetization transfer, spectroscopy) is reproducible; to follow up a cohort of patients with early remmittent MS after treatment with interferon.</brief_summary>
	<brief_title>Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>MS patients according to Poser's criteria Remitting evolution (less than two years of evolution) Aged 1850 Immunomodulatory treatment indicated Unable to perform MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>aged 18-50</keyword>
	<keyword>remitting evolution</keyword>
	<keyword>less than two years of evolution</keyword>
	<keyword>MS patients</keyword>
</DOC>